Life Sciences Key Technologies
Kitchener
About Life Sciences Key Technologies
LSK is looking to tap computer vision to build disease testing hardware (a “lab in a box,” as they put it) small/fast enough to keep in a doctor’s office or workplace. The company says it’s currently running the Zika Virus field trials in Latin America and is looking at how they can bring their computer vision approach in to help tackle the COVID-19 pandemic. They also say they’ve seen over $100,000 in pre-orders to date.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $199.7K
- Funding stage: M&A
- Last round: Seed (Aug 2020)
- Website: lifesci-key.com
Industries & Categories
Biotechnology, Electronic Health Record (EHR), Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/life-sciences-key-technologies-196978 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.